Intuitive Surgical, Inc. $ISRG Holdings Raised by Meitav Investment House Ltd.

Key Points

• Meitav Investment House Ltd. increased its stake in Intuitive Surgical by 2,909.5% in Q2, owning 38,852 shares valued at $21.1 million after purchasing an additional 37,561 shares.
• A number of institutional investors, including Aaron Wealth Advisors LLC and Crown Wealth Group LLC, have also increased their holdings in Intuitive Surgical during the year.
• Key analysts have revised target prices for Intuitive Surgical, with ratings ranging from "overweight" to "sell," and an average target price of $594.19 based on recent analyses.

Meitav Investment House Ltd. lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 2,909.5% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 38,852 shares of the medical equipment provider's stock after purchasing an additional 37,561 shares during the quarter. Meitav Investment House Ltd.'s holdings in Intuitive Surgical were worth $21,125,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Aaron Wealth Advisors LLC grew its stake in shares of Intuitive Surgical by 0.8% in the 2nd quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider's stock valued at $1,374,000 after buying an additional 19 shares in the last quarter. Crown Wealth Group LLC lifted its holdings in Intuitive Surgical by 4.8% in the 1st quarter. Crown Wealth Group LLC now owns 440 shares of the medical equipment provider's stock worth $218,000 after purchasing an additional 20 shares during the last quarter. FSM Wealth Advisors LLC lifted its holdings in Intuitive Surgical by 3.8% in the 1st quarter. FSM Wealth Advisors LLC now owns 546 shares of the medical equipment provider's stock worth $270,000 after purchasing an additional 20 shares during the last quarter. CFO4Life Group LLC lifted its holdings in Intuitive Surgical by 4.8% in the 1st quarter. CFO4Life Group LLC now owns 436 shares of the medical equipment provider's stock worth $216,000 after purchasing an additional 20 shares during the last quarter. Finally, J. W. Coons Advisors LLC lifted its holdings in Intuitive Surgical by 1.4% in the 1st quarter. J. W. Coons Advisors LLC now owns 1,497 shares of the medical equipment provider's stock worth $741,000 after purchasing an additional 20 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, Director Amy L. Ladd sold 335 shares of the company's stock in a transaction on Thursday, September 4th. The stock was sold at an average price of $440.69, for a total value of $147,631.15. Following the sale, the director directly owned 739 shares in the company, valued at $325,669.91. This represents a 31.19% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Myriam Curet sold 4,500 shares of the company's stock in a transaction on Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the sale, the executive vice president owned 353 shares in the company, valued at $173,845.44. This trade represents a 92.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 45,224 shares of company stock worth $21,716,492 over the last three months. Company insiders own 0.70% of the company's stock.

Analyst Ratings Changes

Several equities research analysts recently weighed in on ISRG shares. Piper Sandler restated an "overweight" rating and issued a $595.00 target price (up from $575.00) on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Evercore ISI boosted their target price on Intuitive Surgical from $470.00 to $550.00 and gave the stock an "in-line" rating in a report on Tuesday, July 8th. Deutsche Bank Aktiengesellschaft restated a "sell" rating on shares of Intuitive Surgical in a report on Friday, August 22nd. UBS Group upped their price target on Intuitive Surgical from $547.00 to $585.00 and gave the stock a "neutral" rating in a report on Wednesday, July 23rd. Finally, The Goldman Sachs Group cut their price target on Intuitive Surgical from $621.00 to $567.00 and set a "buy" rating for the company in a report on Wednesday, October 1st. Fourteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus price target of $594.19.

Intuitive Surgical Trading Down 0.6%

ISRG opened at $449.69 on Tuesday. The stock has a market cap of $161.20 billion, a PE ratio of 62.72, a P/E/G ratio of 4.74 and a beta of 1.61. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00. The stock's 50 day simple moving average is $462.67 and its 200-day simple moving average is $499.82.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.93 by $0.26. The business had revenue of $2.44 billion for the quarter, compared to analysts' expectations of $2.35 billion. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.Intuitive Surgical's quarterly revenue was up 21.4% on a year-over-year basis. During the same period in the previous year, the business posted $1.78 earnings per share. Equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.